These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7792290)

  • 1. Cyst fluid NB/70K concentration and leukocyte esterase: two new markers for differentiating pancreatic serous tumors from pseudocysts.
    Yong WH; Southern JF; Pins MR; Warshaw AL; Compton CC; Lewandrowski KB
    Pancreas; 1995 May; 10(4):342-6. PubMed ID: 7792290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
    Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
    Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Alles AJ; Warshaw AL; Southern JF; Compton CC; Lewandrowski KB
    Ann Surg; 1994 Feb; 219(2):131-4. PubMed ID: 8129483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas.
    Hammel P; Levy P; Voitot H; Levy M; Vilgrain V; Zins M; Flejou JF; Molas G; Ruszniewski P; Bernades P
    Gastroenterology; 1995 Apr; 108(4):1230-5. PubMed ID: 7535275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
    Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
    Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts.
    Sperti C; Pasquali C; Pedrazzoli S; Guolo P; Liessi G
    Am J Gastroenterol; 1997 Apr; 92(4):672-5. PubMed ID: 9128321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.
    Rubin D; Warshaw AL; Southern JF; Pins M; Compton CC; Lewandrowski KB
    Surgery; 1994 Jan; 115(1):52-5. PubMed ID: 8284761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyst fluid analysis in the differential diagnosis of pancreatic cysts: a new approach to the preoperative assessment of pancreatic cystic lesions.
    Lewandrowski K; Lee J; Southern J; Centeno B; Warshaw A
    AJR Am J Roentgenol; 1995 Apr; 164(4):815-9. PubMed ID: 7537015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrocystic pancreatic cystadenoma: The role of EUS and cyst fluid analysis in distinguishing mucinous and serous lesions.
    O'Toole D; Palazzo L; Hammel P; Ben Yaghlene L; Couvelard A; Felce-Dachez M; Fabre M; Dancour A; Aubert A; Sauvanet A; Maire F; Lévy P; Ruszniewski P
    Gastrointest Endosc; 2004 Jun; 59(7):823-9. PubMed ID: 15173795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience.
    Linder JD; Geenen JE; Catalano MF
    Gastrointest Endosc; 2006 Nov; 64(5):697-702. PubMed ID: 17055859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
    J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyst fluid cytologic analysis in the differential diagnosis of pancreatic cystic lesions.
    Centeno BA; Lewandrowski KB; Warshaw AL; Compton CC; Southern JF
    Am J Clin Pathol; 1994 Apr; 101(4):483-7. PubMed ID: 8160642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of CA 72-4 and carcinoembryonic antigen determination in the fluid of pancreatic cystic lesions.
    Hammel P; Voitot H; Vilgrain V; Lévy P; Ruszniewski P; Bernades P
    Eur J Gastroenterol Hepatol; 1998 Apr; 10(4):345-8. PubMed ID: 9855052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.
    Sperti C; Pasquali C; Guolo P; Polverosi R; Liessi G; Pedrazzoli S
    Cancer; 1996 Jul; 78(2):237-43. PubMed ID: 8673998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms.
    Haab BB; Porter A; Yue T; Li L; Scheiman J; Anderson MA; Barnes D; Schmidt CM; Feng Z; Simeone DM
    Ann Surg; 2010 May; 251(5):937-45. PubMed ID: 20395854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of gastric mucins (M1 antigens) in cyst fluid for the diagnosis of cystic lesions of the pancreas.
    Hammel PR; Forgue-Lafitte ME; Lévy P; Voitot H; Vilgrain V; Fléjou JF; Molas G; Gespach C; Ruszniewski P; Bernades P; Bara J
    Int J Cancer; 1997 Jun; 74(3):286-90. PubMed ID: 9221806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cystic islet-cell tumors. Clinical and pathologic features in two cases with cyst fluid analysis.
    Weissmann D; Lewandrowski K; Godine J; Centeno B; Warshaw A
    Int J Pancreatol; 1994 Feb; 15(1):75-9. PubMed ID: 8195644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Difficulties of differential diagnosis of pancreatic pseudocysts and cystic neoplasms].
    Zdanyte E; Strupas K; Bubnys A; Stratilatovas E
    Medicina (Kaunas); 2004; 40(12):1180-8. PubMed ID: 15630345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine.
    Park WG; Wu M; Bowen R; Zheng M; Fitch WL; Pai RK; Wodziak D; Visser BC; Poultsides GA; Norton JA; Banerjee S; Chen AM; Friedland S; Scott BA; Pasricha PJ; Lowe AW; Peltz G
    Gastrointest Endosc; 2013 Aug; 78(2):295-302.e2. PubMed ID: 23566642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of pS2 protein in pancreatic cyst fluids. Evidence for a potential role of pS2 protein in the pathogenesis of mucinous cystic tumors.
    Yang JM; Lee J; Southern JF; Warshaw AL; Dhanak E; Lewandrowski KB
    Int J Pancreatol; 1998 Dec; 24(3):181-6. PubMed ID: 9873952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.